Unknown

Dataset Information

0

Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort.


ABSTRACT: We investigated the association of the Finnish Diabetes Risk Score (FINDRISC) with insulin secretion, insulin sensitivity, and risk of type 2 diabetes, drug-treated hypertension, cardiovascular (CVD) events and total mortality in a follow-up study of the Metabolic Syndrome in Men (METSIM) cohort. The METSIM study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. Of 8,749 non-diabetic participants of the METSIM study 693 developed incident type 2 diabetes, 225 started antihypertensive medication, 351 had a CVD event, and 392 died during a 8.2-year follow-up. The FINDRISC was significantly associated with decreases in insulin secretion and insulin sensitivity (P<0.0001), and with a 4.14-fold increased risk of incident type 2 diabetes, 2.43-fold increased risk of drug-treated hypertension, 1.61-fold increased risk of CVD, and 1.55-increased risk of total mortality (the FINDRISC ?12 vs. < 12 points). In conclusion, the FINDRISC predicts impairment in insulin secretion and insulin sensitivity, the conversion to type 2 diabetes, drug-treated hypertension, CVD events and total mortality.

SUBMITTER: Fizelova M 

PROVIDER: S-EPMC5112858 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort.

Fizelova Maria M   Jauhiainen Raimo R   Stančáková Alena A   Kuusisto Johanna J   Laakso Markku M  

PloS one 20161116 11


We investigated the association of the Finnish Diabetes Risk Score (FINDRISC) with insulin secretion, insulin sensitivity, and risk of type 2 diabetes, drug-treated hypertension, cardiovascular (CVD) events and total mortality in a follow-up study of the Metabolic Syndrome in Men (METSIM) cohort. The METSIM study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. Of 8,749 non-diabetic participants of the METSIM study 693 developed incident type 2 diabetes, 225 started anti  ...[more]

Similar Datasets

| S-EPMC3121422 | biostudies-literature
| S-EPMC5148717 | biostudies-literature
| S-EPMC3263888 | biostudies-literature
| S-EPMC2646025 | biostudies-literature
| S-EPMC9874976 | biostudies-literature
| S-EPMC5922313 | biostudies-literature
| S-EPMC4911331 | biostudies-literature
| S-EPMC4184066 | biostudies-literature
| S-EPMC2575233 | biostudies-literature
| S-EPMC2453674 | biostudies-literature